Agents that block TNF, have been shown to significantly reduce joint inflammation, slow radiographic progression of joint damage, and improve physical function in clinical studies of both advanced and early RA [13,18,72,73] and this may have had some influence on the rate of the radiographic progression in this study. The gene discussed is TNF; the disease is rheumatoid arthritis.